222 related articles for article (PubMed ID: 23671718)
21. In utero hematopoietic stem cell transplantation. A status report.
Flake AW; Zanjani ED
JAMA; 1997 Sep; 278(11):932-7. PubMed ID: 9302247
[TBL] [Abstract][Full Text] [Related]
22. In utero transplantation: baby steps towards an effective therapy.
Muench MO
Bone Marrow Transplant; 2005 Mar; 35(6):537-47. PubMed ID: 15665844
[TBL] [Abstract][Full Text] [Related]
23. [Missed opportunities of in utero transfer of very preterm births (24-32 weeks gestation) in Aquitaine, 2003-2005].
Hyvert M; Germain C; Schaeffer V; Joly-Pedespan L; Leroy V
J Gynecol Obstet Biol Reprod (Paris); 2008 Nov; 37(7):705-13. PubMed ID: 18722063
[TBL] [Abstract][Full Text] [Related]
24. Efficient engraftment of in utero transplanted mice with retrovirally transduced hematopoietic stem cells.
Rio P; Martinez-Palacio J; Ramirez A; Bueren JA; Segovia JC
Gene Ther; 2005 Feb; 12(4):358-63. PubMed ID: 15550924
[TBL] [Abstract][Full Text] [Related]
25. Alloreactivity following in utero transplantation of cytokine-stimulated hematopoietic stem cells: the role of recipient CD4(-) cells.
Sefrioui H; Donahue J; Srivastava AS; Gilpin E; Lee TH; Carrier E
Exp Hematol; 2002 Jun; 30(6):617-24. PubMed ID: 12063030
[TBL] [Abstract][Full Text] [Related]
26. Cardiac injury protection from mouse bone marrow stromal cells with in utero transplantation followed by secondary postnatal boost.
Chung YS; Huang CY; Ma MC; Chu CC; Chiang HS; Lin LJ; Chou SH
Chin J Physiol; 2011 Aug; 54(4):205-18. PubMed ID: 22129818
[TBL] [Abstract][Full Text] [Related]
27. Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation.
Kandasamy K; Tan LG; B Johana N; Tan YW; Foo W; Yeo JSL; Ravikumar V; Ginhoux F; Choolani M; Chan JKY; Mattar CNZ
FASEB J; 2021 Mar; 35(3):e21413. PubMed ID: 33570785
[TBL] [Abstract][Full Text] [Related]
28. Chimerism and tolerance post-in utero transplantation with embryonic stem cells.
Moustafa ME; Srivastava AS; Nedelcu E; Donahue J; Gueorguieva I; Shenouda SS; Minev B; Carrier E
Transplantation; 2004 Nov; 78(9):1274-82. PubMed ID: 15548963
[TBL] [Abstract][Full Text] [Related]
29. Tolerance and immunity following in utero transplantation of allogeneic fetal liver cells: the cytokine shift.
Sefrioui H; Donahue J; Gilpin EA; Srivastava AS; Carrier E
Cell Transplant; 2003; 12(1):75-82. PubMed ID: 12693667
[TBL] [Abstract][Full Text] [Related]
30. Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature.
Kreger EM; Singer ST; Witt RG; Sweeters N; Lianoglou B; Lal A; Mackenzie TC; Vichinsky E
Prenat Diagn; 2016 Dec; 36(13):1242-1249. PubMed ID: 27862048
[TBL] [Abstract][Full Text] [Related]
31. In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants.
Peranteau WH
Front Pharmacol; 2014; 5():251. PubMed ID: 25429269
[TBL] [Abstract][Full Text] [Related]
32. Microchimerism does not induce tolerance and sustains immunity after in utero transplantation.
Donahue J; Gilpin E; Lee TH; Busch MP; Croft M; Carrier E
Transplantation; 2001 Feb; 71(3):359-68. PubMed ID: 11233894
[TBL] [Abstract][Full Text] [Related]
33. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
34. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
Bhattacharyya S; Cowan MJ
Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
[TBL] [Abstract][Full Text] [Related]
35. In utero hematopoietic stem cell transfer: current status and future strategies.
Surbek DV; Gratwohl A; Holzgreve W
Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):109-15. PubMed ID: 10428333
[TBL] [Abstract][Full Text] [Related]
36. In utero hematopoietic stem cell transplants for inherited diseases.
Cowan MJ; Golbus M
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):35-42. PubMed ID: 7906103
[TBL] [Abstract][Full Text] [Related]
37. Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.
Vrecenak JD; Pearson EG; Santore MT; Todorow CA; Li H; Radu A; Bhatti T; Peranteau WH; Johnson MP; Flake AW
Blood; 2014 Sep; 124(12):1987-95. PubMed ID: 24869940
[TBL] [Abstract][Full Text] [Related]
38. Reconstitution of self-tolerance after hematopoietic stem cell transplantation.
Hess AD
Immunol Res; 2010 Jul; 47(1-3):143-52. PubMed ID: 20066509
[TBL] [Abstract][Full Text] [Related]
39. In-utero stem cell transplantation: clinical use and therapeutic potential.
De Santis M; De Luca C; Mappa I; Cesari E; Quattrocchi T; Spagnuolo T; Visconti D; Noia G; Caruso A
Minerva Ginecol; 2011 Aug; 63(4):387-98. PubMed ID: 21747347
[TBL] [Abstract][Full Text] [Related]
40. Maternal-fetal relationship, natural chimerism and bilateral transplantation tolerance as the basis for non-myeloablative stem cell transplantation.
Slavin S
Int J Hematol; 2002 Aug; 76 Suppl 1():172-5. PubMed ID: 12430849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
